- Tytuł:
- Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet Oncology January 2020 21(1):105-120
Czasopismo naukowe